This is an archived release.
Norway and Denmark more expensive than Sweden
Prices of pharmaceuticals are much lower in Norway than in the two other EFTA countries Switzerland and Iceland, and roughly similar to the price level in neighbouring Denmark. However, this is far above the price level in Sweden and in Europe as a whole.
Relative price levels of pharmaceuticals,
Europe 2005. EU25=100
|Former Yugoslav Republic of Macedonia||58|
Switzerland and Iceland stand apart from the other countries in this survey, with price levels far above the European average: Switzerland was 87 per cent and Iceland 60 per cent above the average of the (then) 25 EU member countries. Norway and Denmark are about 20 per cent above the EU25 average, whereas Sweden’s price level is remarkably lower.
Considerable price difference in Europe
The price level differences of pharmaceuticals across Europe are remarkable. If we focus on the EU member countries only, the price levels in countries like Poland, Lithuania, Slovakia and the Czech Republic are typically 40-50 per cent lower than in Germany, which comes out on top. The price difference is less pronounced for original, branded products than for so-called “generic products”. The latter are not protected by patents, and are frequently produced for the domestic market only.
The survey was carried out by Eurostat, the statistical office of the European Commission, in cooperation with 33 European countries in November 2005. Prices of 181 pharmaceutical products were compared across the participating countries. The survey is based on total prices, i.e. the sum of what the customer has to pay and the price subsidy paid by Social Security.
Read more about this survey in Eurostat’s " Statistics in Focus ".